Ludvig A. Munthe

3.8k total citations · 1 hit paper
76 papers, 2.4k citations indexed

About

Ludvig A. Munthe is a scholar working on Immunology, Genetics and Infectious Diseases. According to data from OpenAlex, Ludvig A. Munthe has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 20 papers in Genetics and 17 papers in Infectious Diseases. Recurrent topics in Ludvig A. Munthe's work include T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (24 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Ludvig A. Munthe is often cited by papers focused on T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (24 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Ludvig A. Munthe collaborates with scholars based in Norway, United States and Switzerland. Ludvig A. Munthe's co-authors include Geir E. Tjønnfjord, Bjarne Bogen, Fridtjof Lund‐Johansen, Pål André Holme, Anne Hege Aamodt, Markus Wiedmann, Nina Haagenrud Schultz, Annika E. Michelsen, Thor Håkon Skattør and Ingvild Hausberg Sørvoll and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Ludvig A. Munthe

72 papers receiving 2.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

2021 969 citations Ingvild Hausberg Sørvoll, Ludvig A. Munthe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ludvig A. Munthe Norway	22	937	675	567	482	461	76	2.4k
Michael Nardi United States	27	406 0.4×	179 0.3×	1.3k 2.3×	152 0.3×	279 0.6×	81	2.2k
Aaron S. Rosenberg United States	24	694 0.7×	229 0.3×	458 0.8×	438 0.9×	57 0.1×	87	1.9k
Christophe Marzac France	19	883 0.9×	287 0.4×	1.7k 3.0×	366 0.8×	890 1.9×	58	2.5k
Karl‐Walter Sykora Germany	20	580 0.6×	85 0.1×	755 1.3×	518 1.1×	172 0.4×	45	2.2k
Tayfun Güngör Switzerland	26	842 0.9×	163 0.2×	1.1k 2.0×	193 0.4×	154 0.3×	88	2.4k
Hérvè Chambost France	32	941 1.0×	157 0.2×	2.2k 3.9×	600 1.2×	92 0.2×	134	3.8k
Gilles Thibault France	27	1.3k 1.4×	368 0.5×	237 0.4×	830 1.7×	52 0.1×	80	2.5k
Anne Huynh France	28	359 0.4×	106 0.2×	1.6k 2.9×	593 1.2×	141 0.3×	130	2.7k
Spero R. Cataland United States	33	2.7k 2.9×	138 0.2×	1.7k 3.0×	135 0.3×	163 0.4×	113	3.7k
Anna Linda Zignego Italy	46	468 0.5×	753 1.1×	218 0.4×	567 1.2×	315 0.7×	177	7.0k

Countries citing papers authored by Ludvig A. Munthe

Since Specialization

Citations

This map shows the geographic impact of Ludvig A. Munthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludvig A. Munthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludvig A. Munthe more than expected).

Fields of papers citing papers by Ludvig A. Munthe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludvig A. Munthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludvig A. Munthe. The network helps show where Ludvig A. Munthe may publish in the future.

Co-authorship network of co-authors of Ludvig A. Munthe

This figure shows the co-authorship network connecting the top 25 collaborators of Ludvig A. Munthe. A scholar is included among the top collaborators of Ludvig A. Munthe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludvig A. Munthe. Ludvig A. Munthe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsykunova, Galina, Pål André Holme, Hoa Tran, et al.. (2025). Safety and efficacy of daratumumab in immune thrombocytopenia. Blood Advances. 10(1). 143–154.

Våtsveen, Thea Kristin, Andrej Bešše, Sigrid S. Skånland, et al.. (2025). Targeting proteostasis in multiple myeloma through inhibition of LTK. Leukemia. 39(9). 2237–2245. 1 indexed citations

Richman, Alyssa, Péter Szodoray, Ann Kristin Kvam, et al.. (2024). Transcriptome analysis of primary adult B ‐cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis. European Journal Of Haematology. 112(5). 731–742. 4 indexed citations

Kared, Hassen, Ingrid M. Egner, Trung Tran, et al.. (2024). Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study. Frontiers in Immunology. 15. 1296273–1296273. 3 indexed citations

Sexton, Joseph, Anne Therese Tveter, Siri Mjaaland, et al.. (2024). Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study. RMD Open. 10(2). e003545–e003545. 3 indexed citations

Skeie, Linda Gail, Ingrid M. Egner, Adity Chopra, et al.. (2024). Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections. npj Vaccines. 9(1). 185–185. 2 indexed citations

Małecka, Agnieszka, Gunhild Trøen, Jędrzej Małecki, et al.. (2023). Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease. Clinical & Experimental Immunology. 216(1). 45–54. 6 indexed citations

Tveita, Anders, et al.. (2023). A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine. Cell Death Discovery. 9(1). 125–125. 10 indexed citations

Kared, Hassen, Asia‐Sophia Wolf, Anthony Ravussin, et al.. (2022). Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nature Communications. 13(1). 4165–4165. 41 indexed citations

10.

Raj, Deepak B. Thimiri Govinda, Sigrid S. Skånland, Geir E. Tjønnfjord, et al.. (2022). Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically. Molecular Oncology. 16(6). 1241–1258. 14 indexed citations

11.

Syversen, Silje Watterdal, Anne Therese Tveter, Joe Sexton, et al.. (2022). Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy. RMD Open. 8(2). e002417–e002417. 10 indexed citations

12.

Huse, Kanutte, Baoyan Bai, Thea Kristin Våtsveen, et al.. (2022). Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression. The Journal of Immunology. 209(10). 2042–2053. 32 indexed citations

13.

Strefford, Jonathan C., Francesco Forconi, Freda K. Stevenson, et al.. (2022). B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells. SHILAP Revista de lepidopterología. 3. 37–49. 3 indexed citations

14.

Huszthy, Peter C., Johanne T. Jacobsen, Ole Audun Werner Haabeth, et al.. (2019). B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells. Proceedings of the National Academy of Sciences. 116(51). 25850–25859. 13 indexed citations

15.

Kushekhar, Kushi, Ludvig A. Munthe, Geir E. Tjønnfjord, et al.. (2019). The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function. The Journal of Immunology. 202(5). 1397–1405. 106 indexed citations

16.

Skånland, Sigrid S., et al.. (2019). An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL. Leukemia. 34(2). 478–487. 25 indexed citations

17.

Szodoray, Péter, Stephanie M. Stanford, Øyvind Molberg, et al.. (2016). T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity. Journal of Allergy and Clinical Immunology. 138(3). 839–851.e8. 20 indexed citations

18.

Selmer, Kaja Kristine, Gregor D. Gilfillan, Petter Strømme, et al.. (2011). A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions. European Journal of Human Genetics. 20(1). 58–63. 21 indexed citations

19.

Munthe, Ludvig A., et al.. (2005). Systemic Autoimmune Disease Caused by Autoreactive B Cells That Receive Chronic Help from Ig V Region-Specific T Cells. The Journal of Immunology. 175(4). 2391–2400. 43 indexed citations

20.

Munthe, Ludvig A., et al.. (2004). MHC-Restricted Ig V Region-Driven T-B Lymphocyte Collaboration: B Cell Receptor Ligation Facilitates Switch to IgG Production. The Journal of Immunology. 172(12). 7476–7484. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact